The effect of NBS powder in treatment of patients with COVID-19
Phase 3
Recruiting
- Conditions
- COVID-19 pneumonia.COVID-19,U07.2
- Registration Number
- IRCT20200426047206N1
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
Covid 19 positive patients with with age over 20 years
Exclusion Criteria
Disagreement of the patient or relatives to participate in the project
Drug sensitivity to NBS
Patient death during common and selective treatments
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pulmonary symptoms. Timepoint: 4 weeks after intervention. Method of measurement: CT Scan.
- Secondary Outcome Measures
Name Time Method